Limitless Black Edition 7-OH Tablets feature a premium 7-hydroxymitragynine formulation in a convenient chewable tablet format designed for users seeking concentrated alkaloid content in a compact pouch. Each pack contains 2 chewable tablets totaling 100mg, offering a portable format that's easy to carry, store, and portion throughout the day.
With 50mg of 7-hydroxymitragynine per tablet, each tablet is designed with an 8-serving format for added portioning flexibility. The chewable format eliminates the need for powders, capsules, or mixing, while the sealed pouch helps keep each tablet protected and individually secured for convenient everyday use or travel.
50mg Per Tablet: Premium 7-hydroxymitragynine formulation in every chewable tablet.
100mg Total Per Pack: Two-tablet pouch delivering concentrated total alkaloid content.
8-Serving Tablet Design: Each tablet is designed to be portioned into smaller servings for greater flexibility.
Chewable Format: No powders, capsules, or additional preparation required.
Sealed Pouch Packaging: Helps keep each tablet protected, organized, and ready for storage, travel, or everyday carry.
This product is not available for shipment to the following states: Alabama, Arkansas, Connecticut, Florida, Indiana, Louisiana, Wisconsin; or the following counties: Sarasota County (Florida), San Diego (California), Oceanside (California), Alton (Illinois), Jerseyville (Illinois), Edwardsville County (Illinois), Columbus (Mississippi), Union County (Mississippi).
FDA DISCLAIMER: The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your health care professional about potential interactions or other possible complications before using any product. The Federal Food, Drug, and Cosmetic Act require this notice.
